Global Opportunities in Neurostimulation Technologies Markets Targeting Chronic Pain
Order individually or subscribe to Medtech Pro and get a complete intel platform.
Overview
The global market for neurostimulation devices targeting chronic pain was estimated at $2.52 billion in 2018, comprised almost exclusively of spinal cord stimulation (SCS) systems. Peripheral nerve stimulation (PNS) represent a much newer development that has only emerged as a meaningful segment with the introduction of next-generation products featuring miniature neurostimulators that communicate with external power sources via wireless technology. Global sales of these next generation PNS systems were estimated at only $13.3 million in 2018 but are expected to see 34.7% real annual sales growth through 2024 to nearly $80 million as device sales increase from 2,000 in 2018 to 11,675 in 2024. A detailed analysis of the global neurostimulation devices market and the competitive landscape is included in this new report.
Companies Covered
Abbott/St. Jude Medical
Bioness
BlueWind
Boston Scientific
Medtronic
Mainstay
Nalu Medical
Nevro
Nuvectra
Saluda Medical
SPR Therapeutics
Stimwave
Other Emerging Players
Table of Contents
Executive Summary
Prevalence of High Impact Chronic Pain
Neurostimulation Technologies Targeting High Impact Chronic Pain
Product Markets
Supplier Shares
Summary Exhibit 1: Trend in Adults Experiencing High Impact Chronic Pain, by Major Geography, 2018-2024
Summary Exhibit 2: Major Neurostimulation Approaches to Chronic Pain
Summary Exhibit 3: Global Spinal Cord and Peripheral Nerve Stimulation, Implantations and Product Sales, 2018-2024
Summary Exhibit 4: Global Market for Neurostimulation Technologies Targeting High Impact Chronic Pain, by Major Geography, 2018-2024
Summary Exhibit 5: Neurostimulation Systems Targeting High Impact Chronic Pain, Supplier Share, 2018
1. Epidemiology of Chronic Pain
1.1 Neurobiology of Pain
1.2 Chronic Pain
1.2.1High Impact Chronic Pain
1.2.2 Prevalence
Exhibit 1-1: Estimated Global Adults with Chronic Pain and High-Impact Chronic Pain, 2018
Exhibit 1-2: Trend in Adults Experiencing High Impact Chronic Pain, by Major Geography, 2018-2024
2. Products and Technologies
2.1 Spinal Cord Stimulation Systems
2.1.1Nalu Medical
2.1.2Nevro
2.1.3Stimwave
2.1.4Saluda Medical
2.2 Peripheral Nerve Stimulation Systems
2.2.1Bioness
2.2.2 BlueWind Medical
2.2.3 Mainstay Medical
2.2.4 Neuros Medical
2.2.5 SPR Therapeutics
2.2.6 Stimwave
Exhibit 2-1: Comparison of Major Neurostimulation Approaches to Chronic Pain
Exhibit 2-2: Selected Spinal Cord Stimulation Systems, 2019
Exhibit 2-3: Selected Peripheral Nerve Stimulation, 2019
3. Markets
3.1 Global Supplier Shares
3.2 Market by Major Geography
3.2.1 United States
3.2.2 Major Europe
3.2.3 Major Asia-Pacific
Exhibit 3-1: Global Spinal Cord and Peripheral Nerve Stimulation, Implantations and Product Sales, 2018-2024
Exhibit 3-2: Neurostimulation Systems Targeting Chronic Pain, Supplier Shares, 2019
Exhibit 3-3: Global Market for Neurostimulation Technologies Target Chronic Pain, by Major Geography, 2018-2024
Exhibit 3-4: U.S. Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024
Exhibit 3-5: Neurostimulation Systems Targeting Chronic Pain, U.S. Supplier Shares, 2018
Exhibit 3-6: Major Europe Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024
Exhibit 3-7: Neurostimulation Systems Targeting Chronic Pain, Major Europe Supplier Shares, 2018
Exhibit 3-8: Major Asia-Pacific Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024
Exhibit 3-9: Neurostimulation Systems Targeting Chronic Pain, Major Asia-Pacific Supplier Shares, 2018
Exhibit 3-10: Rest-of-World Market for Neurostimulation Technologies Targeting Chronic Pain, 2018-2024
Exhibit 3-11: Neurostimulation Systems Targeting Chronic Pain, Rest-of-World Supplier Shares, 2018
